Homeopathic Arnica Tablets Recalled for Manufacturing Process Deviations
Pharmadel, LLC is recalling Rapidol Arnica Tablets due to cGMP deviations in the manufacturing process. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for manufacturing practice deviations (cGMP) with no reported illnesses or injuries. Per the rubric, voluntary precautionary recalls with no documented harm receive a Moderate (2) severity score.
Plain-English summary
Pharmadel, LLC is recalling Rapidol Arnica Tablets, a homeopathic medicine sold in 100-count bottles (NDC 55758-405-99). The recalled product corresponds to lot EAT-01 with an expiration date of March 27. Approximately 6,048 bottles were distributed in Delaware.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations in the manufacturing process. cGMP violations represent a failure to meet FDA manufacturing standards. Pharmadel initiated this voluntary recall after identifying the manufacturing deviations.
No illnesses or injuries related to this product have been reported. The recall was voluntarily initiated by the firm and was terminated on January 8, 2026.
The recalled product
- Product
- Rapidol Arnica Tablets, Homeopathic Medicine, 100-count bottle, Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-405-99
- Manufacturer
- Pharmadel, LLC
- Category
- Drug — Homeopathic Medicine
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot
- expiry: EAT-01
- EXP: MAR 27
Distribution
Distributed in 1 state:
- DE
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27